TMCI - Treace Medical Concepts, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Treace Medical Concepts, Inc.

100 Palmetto Park Place
Ponte Vedra, FL 32081
United States
904 373 5940

IndustryMedical Devices
Full-time employees423

Key executives

NameTitlePayExercisedYear born
Mr. John T. TreaceCEO, Founder & Director1.04MN/A1972
Mr. Mark L. Hair CPAChief Financial Officer628.6kN/A1971
Mr. Aaron J. BeruttiSr. VP of Sales519.41kN/A1979
Mr. Terry W. LubbenSr. VP of OperationsN/AN/A1965
Mr. Scot M. ElderChief Legal & Compliance Officer and Corp. Sec.N/AN/A1975
Mr. Daniel E. OwensChief HR OfficerN/AN/A1972
Mr. Jaime A. FriasChief Bus. Devel. OfficerN/AN/A1962
Dr. Sean F. Scanlan Ph.D.Chief Innovation OfficerN/AN/A1983
Ms. Shana ZinkSr. VP of Clinical Affairs, Medical Education & ReimbursementN/AN/AN/A
Ms. Rachel OsbeckSr. VP of Quality Assurance & Regulatory AffairsN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Corporate governance

Treace Medical Concepts, Inc.’s ISS governance QualityScore as of 1 June 2023 is 8. The pillar scores are Audit: 6; Board: 9; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.